openPR Logo
Press release

Bleeding Disorder Treatment Market is Growing at a CAGR of 7.3% by 2035 | Fact.MR

07-02-2025 06:47 PM CET | Health & Medicine

Press release from: Fact.MR

The global bleeding disorder treatment market, valued at USD 16.0 billion in 2024, is projected to expand at a robust compound annual growth rate (CAGR) of 7.3%, reaching USD 35 billion by 2035, according to a comprehensive report by Fact.MR. This significant growth is driven by high investments in research and development (R&D) for recombinant factors, advancements in treatment technologies, and increasing awareness of bleeding disorders such as hemophilia and von Willebrand disease.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7281

Transforming Lives with Advanced Treatment Solutions

Bleeding disorders, including hemophilia A, hemophilia B, von Willebrand disease, and other rare coagulation factor deficiencies, impair the body's ability to form blood clots, leading to excessive or prolonged bleeding. The market for bleeding disorder treatments is witnessing a surge due to innovative therapies that enhance patient outcomes, such as recombinant coagulation factor concentrates, gene therapies, and non-factor replacement therapies. These advancements are improving quality of life for patients by reducing bleeding episodes and managing complications like joint damage and chronic pain.

From 2020 to 2024, the market grew at a CAGR of 6.7%, reflecting steady progress in treatment accessibility and innovation. The forecast period from 2025 to 2035 is expected to create an absolute opportunity of USD 18 billion, driven by rising prevalence, early diagnosis, and a facilitative regulatory environment that accelerates the approval of novel therapies.

Key Drivers of Market Growth

High Investments in R&D: Pioneering Recombinant Therapies

A major driver of the bleeding disorder treatment market is the significant investment in R&D for recombinant factors, which offer consistent potency, longer shelf life, and fewer side effects compared to plasma-derived products. For instance, in October 2024, Pfizer's Hympavzi (marstacimab-hncq) received FDA approval for routine prophylaxis in hemophilia A and B patients, reducing annualized bleeding rates through a novel mechanism that enhances thrombin generation. Such innovations are expanding treatment options and driving market growth.

Advancements in Treatment Technologies

Technological advancements, including extended half-life factor concentrates and gene therapies, are revolutionizing bleeding disorder management. Gene therapies, such as BioMarin's valoctocogene roxaparvovec for hemophilia A and Freeline Therapeutics' FLT180a for hemophilia B, are showing promising results in clinical trials, offering the potential for long-term or curative outcomes. These therapies reduce the frequency of infusions and improve patient compliance, further fueling market expansion.

Rising Prevalence and Awareness

The increasing prevalence of bleeding disorders, driven by genetic factors, aging populations, and lifestyle changes, is boosting demand for treatments. Improved diagnostics and awareness campaigns by organizations like the World Federation of Hemophilia (WFH) are leading to earlier diagnoses, particularly in developing countries. For example, the WFH's Humanitarian Aid Program, extended by Roche until 2028, has provided prophylactic treatment to over 940 patients across 30 countries, enhancing access and driving market growth.

Personalized Medicine and Regulatory Support

The trend toward personalized medicine, tailoring treatments to individual patient needs, is improving compliance and satisfaction. Favorable regulatory frameworks, such as the U.S. Orphan Drug Act, incentivize the development of therapies for rare diseases like hemophilia, accelerating market entry for innovative treatments. Collaborations between pharmaceutical companies and research institutions are further broadening the therapeutic landscape.

Regional Insights: North America Leads, Asia-Pacific Gains Momentum

North America holds the largest market share, driven by advanced healthcare infrastructure, high patient awareness, and robust reimbursement policies. The U.S. market is expected to grow at a CAGR of 7.2% through 2035, supported by significant R&D investments and approvals like Takeda's VONVENDI for von Willebrand disease prophylaxis in January 2022.

The Asia-Pacific region is poised for rapid growth, with markets like China and India benefiting from rising diagnosis rates and increasing healthcare expenditure. Japan's market is projected to grow at a CAGR of 5.7%, driven by advancements in genetic research and government support. Emerging markets in Latin America and the Middle East & Africa are also expanding due to improved access to treatments and growing awareness.

Industry Trends and Innovations

The bleeding disorder treatment market is shaped by several key trends:

Gene Therapy Advancements: Preclinical and clinical trials for gene therapies, such as Metagenomi's MGX-001 for hemophilia A and Belief Biomed's BBM-H901 for hemophilia B, are pushing the boundaries of curative treatments. In April 2025, BBM-H901 was approved in China, demonstrating stable factor IX expression and reduced bleeding rates.

Non-Factor Therapies: Novel therapies like Pfizer's Hympavzi, which target tissue factor pathway inhibitors, are offering once-weekly subcutaneous options, improving patient convenience and outcomes.

Prophylactic Treatments: Prophylaxis is gaining traction, particularly for severe hemophilia, reducing joint damage and bleeding risks. Extended half-life therapies are enhancing prophylactic efficacy, driving adoption.

Collaborative Initiatives: Partnerships, such as the National Hemophilia Foundation's "Together Project" with the Hemophilia Federation of America in September 2021, are aligning resources to improve patient care and drive market growth.

Browse Full Report: https://www.factmr.com/report/bleeding-disorders-treatment-market

Challenges and Opportunities

The market faces challenges, including high treatment costs, which can limit accessibility, particularly in low-resource countries. Shortages of specialized clinicians and unfavorable reimbursement policies in some regions also hinder growth. Additionally, regulatory complexities for approving advanced therapies like gene therapy can delay market entry.

However, these challenges present opportunities. The rise of DaaS (Drug-as-a-Service) models and generic therapies, such as Avenacy's generic DDAVP launched in April 2024 for mild hemophilia A, are improving affordability. Increased funding for R&D and patient advocacy programs, such as the Kevin Child Scholarship by the Hemophilia Federation of America, are enhancing access and awareness, particularly in emerging markets.

Future Outlook: A Promising Horizon

The bleeding disorder treatment market is set for robust growth, driven by innovations in recombinant factors, gene therapies, and non-factor treatments. As awareness, diagnosis rates, and access to advanced therapies improve, the market will continue to transform patient outcomes. Strategic collaborations, regulatory support, and investments in R&D will be critical for addressing challenges and sustaining growth.

Fact.MR's detailed report provides comprehensive insights into the global bleeding disorder treatment market, covering historical data from 2020 to 2024 and forecast statistics for 2025 to 2035. The report includes market trends, competitive analysis, and regional forecasts for North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.

Check out More Related Studies Published by Fact.MR:

Psychotic Disorder Treatment Market: https://www.factmr.com/report/568/psychotic-disorder-treatment-market

Choroid Plexus Disorder Treatment Market: https://www.factmr.com/report/choroid-plexus-disorder-treatment-market

Movement Disorder Market: https://www.factmr.com/report/329/movement-disorder-market

Achalasia Treatment Market: https://www.factmr.com/report/992/achalasia-treatment-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bleeding Disorder Treatment Market is Growing at a CAGR of 7.3% by 2035 | Fact.MR here

News-ID: 4090167 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for America

Stabilit America Highlights Applications of Fiberglass Roof Panels with Stabilit …
Roofing materials are very important in the realm of modern construction, as they should be long lasting, economical and attractive. Fiberglass roof panels are a few of the numerous choices among several alternatives that have received a reputation of being versatile, long life, and adaptable in various sectors. They are favored by the architects, contractors, and property developers due to their lightweight construction, resistance to weather factors, and the ease
Deodorants Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Deodorants market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Sequestrant Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Sequestrant market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Buttermilk Market Study by Region (North America, Latin America, Europe, Asia, M …
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Buttermilk market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%),
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth